Compounded weight-loss drugs raise serious patient safety concerns

Written on 15/05/2026
Jeremy Maggs

‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr.
Read full article